Avalyn Announces Closing of Initial Public Offering and Full Exercise of Underwriters’ Option to Purchase Additional Shares
Avalyn Pharma closed its initial public offering, selling 19.2 million shares at $18.00 apiece for gross proceeds of $345 million. The deal included the full exercise of the underwriters' option to purchase an additional 2.5 million shares.
Key figures
- Deal Value Usd
- 345000000
- Offering Price
- 18
- Shares Offered
- 19166667
- Greenshoe shares
- 2500000
AI analysis
The rest of the AI analysis, red flags and sentiment are part of Signal8 Pro.
AI-generated analysis of a public disclosure. Not investment advice; verify against the original document.